NASDAQ
Calliditas Therapeutics AB (publ) (CALT) has a revenue compound annual growth rate of 375.40% over 5 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.